Riedl Jana C, Schuster Alexander K, Vossmerbaeumer Urs
Augenklinik und Poliklinik, Universitätsmedizin Mainz, Langenbeckstr. 1, 55131, Mainz, Deutschland.
Ophthalmologe. 2020 Aug;117(8):786-790. doi: 10.1007/s00347-020-01043-3. Epub 2020 Feb 14.
The implantation of the Artificial Iris® (Human Optics AG, Erlangen, Germany) is used for pupil and iris reconstruction in patients with partial or complete aniridia. So far, only a few case reports and short-term results are available in the literature.
The aim of this analysis is to present the various indications as well as the functional result.
This retrospective consecutive case study included 51 eyes of 50 patients with implantation of an Artificial Iris® for pupillary reconstruction. All operations were performed by the same ophthalmic surgeon (UV) at the University Eye Clinic Mainz. The initial findings were placed in relation to the indications and the functional results were investigated.
In this study 51 eyes of 50 patients with a mean age of 57 ± 16.5 years (16 women and 34 men) were analyzed. While the majority of the patients suffered from a traumatic partial or complete aniridia, the minority showed congenital defects. The visual acuity could be improved in 53% of the patients (p = 0.0001) postoperatively.
This analysis highlights the various and diverse indications for implanting the Artificial Iris®. Hereby, a gain in visual acuity is not invariably the primary objective but more often reduction of glare as well as cosmetic rehabilitation, as the eyes are severely damaged in many cases. The long-term results are currently being analyzed in a study and will soon be published.
人工虹膜（德国埃尔朗根市Human Optics AG公司）植入术用于部分或完全无虹膜患者的瞳孔和虹膜重建。迄今为止，文献中仅有少数病例报告和短期结果。
本分析旨在介绍各种适应证以及功能结果。
这项回顾性连续病例研究纳入了50例植入人工虹膜进行瞳孔重建的患者的51只眼。所有手术均由美因茨大学眼科诊所的同一位眼科医生（UV）进行。将初始检查结果与适应证相关联，并对功能结果进行研究。
本研究分析了50例患者的51只眼，平均年龄为57±16.5岁（16名女性和34名男性）。大多数患者患有外伤性部分或完全无虹膜，少数患者表现为先天性缺陷。术后53%的患者视力得到改善（p = 0.0001）。
本分析强调了人工虹膜植入的各种不同适应证。因此，提高视力并非总是主要目标，而更多的是减少眩光以及进行美容修复，因为在许多情况下眼睛受到了严重损伤。目前正在一项研究中分析长期结果，不久将发表。
